AI For Pharma Growth

E241: Beyond the Survey: How Generative AI Captures the Patient Voice at Scale — and Why It's Pharma's Next Growth Lever

5 snips
Oct 28, 2026
Mattia Marco Caruson, co-founder and CEO of mama health, brings pharma commercial expertise to the patient intelligence revolution. He explores why surveys and focus groups miss crucial lived experiences, how generative AI turns open-ended patient stories into structured insight, and what this means for launches, market access, medical affairs and support. They also tackle consent, privacy, hallucinations and trusted medical sources.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

Doctors Couldn’t See The Hidden Patient Journey

  • Mattia Marco Caruson found doctors could not reliably describe what happened during patients’ seven- or eight-year diagnostic journeys.
  • AI made open-ended patient conversations scalable and converted qualitative stories into structured insight.
INSIGHT

Clinicians Cannot Represent Twenty Four Hours

  • Pharma’s reliance on clinician perspectives reflects access limitations rather than proof that clinicians represent the whole patient population.
  • Patients’ lived experience extends across every hour of the day, not only clinical encounters.
INSIGHT

AI Unlocks New Research Capabilities

  • Many executives treat AI as a modest efficiency tool, missing its ability to make previously impossible activities feasible.
  • Conversational AI can process thousands of patient stories in ways traditional research could not.
Get the Snipd Podcast app to discover more snips from this episode
Get the app